Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites
Drug Metabolism and Disposition - United States
doi 10.1124/dmd.116.071613
Full Text
Open PDFAbstract
Available in full text
Date
December 19, 2016
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)